NeuroBo Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
MTVA
CUSIP
64132R404
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 64132R404 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 2
4.99% 8/14/2025
Event 6/30/2025
Dong-A ST Co., Ltd. 13D/A Amendment 8
51.1% 5/20/2025
Event 5/8/2025
Armistice Capital, LLC 13G/A Amendment 1
10.0% 5/15/2025
Event 3/31/2025
Armistice Capital, LLC 13G
10.0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 16 452 k $425 k
2025 Q2 16 266 k $171 k
2025 Q1 15 713 k $1.10 M
2024 Q4 16 906 k $1.84 M
2024 Q3 15 1.09 M $3.47 M
2024 Q2 15 892 k $4.32 M
2024 Q1 17 97.4 k $399 k
2023 Q4 10 66.5 k $245 k